CODULLO, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.801
AS - Asia 1.334
EU - Europa 1.218
SA - Sud America 222
AF - Africa 72
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.655
Nazione #
US - Stati Uniti d'America 1.749
CN - Cina 520
SG - Singapore 339
IE - Irlanda 251
DE - Germania 230
BR - Brasile 160
RU - Federazione Russa 159
VN - Vietnam 145
HK - Hong Kong 143
FI - Finlandia 141
IT - Italia 91
FR - Francia 70
AT - Austria 60
GB - Regno Unito 54
BD - Bangladesh 50
IN - India 46
ZA - Sudafrica 44
UA - Ucraina 41
SE - Svezia 34
CA - Canada 32
JP - Giappone 21
AR - Argentina 20
NL - Olanda 16
IQ - Iraq 14
PL - Polonia 14
CO - Colombia 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
MA - Marocco 9
SA - Arabia Saudita 9
BE - Belgio 8
ES - Italia 8
MX - Messico 8
MY - Malesia 7
UZ - Uzbekistan 7
VE - Venezuela 7
BO - Bolivia 5
ID - Indonesia 5
KE - Kenya 5
CL - Cile 4
MK - Macedonia 4
PK - Pakistan 4
TN - Tunisia 4
TR - Turchia 4
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KR - Corea 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 4.655
Città #
Dublin 247
Chandler 227
San Jose 221
Singapore 190
Ashburn 181
Dallas 153
Hong Kong 141
Munich 141
Beijing 121
Helsinki 85
Nanjing 84
Jacksonville 71
Los Angeles 57
Boardman 53
Vienna 53
Ho Chi Minh City 47
New York 47
Lauterbourg 44
Johannesburg 38
Council Bluffs 36
Princeton 36
Lawrence 35
Nanchang 34
Shanghai 32
Hanoi 28
Medford 28
Shenyang 27
São Paulo 27
Moscow 26
Wilmington 24
Buffalo 22
Orem 22
Turku 22
Pavia 21
Tokyo 20
Milan 18
Seattle 18
Jiaxing 17
Changsha 15
Hebei 14
Hangzhou 13
Redondo Beach 13
Santa Clara 13
Ann Arbor 12
Chennai 12
London 12
Montreal 12
Warsaw 12
Amsterdam 10
Da Nang 10
Poplar 10
Brno 9
Denver 9
Haiphong 9
San Francisco 9
The Dalles 9
Toronto 9
Atlanta 8
Brooklyn 8
Brussels 8
Frankfurt am Main 8
Houston 8
Rio de Janeiro 8
Tianjin 8
Woodbridge 8
Chicago 7
Falkenstein 7
Norwalk 7
Pune 7
Stockholm 7
Baghdad 6
Boston 6
Columbus 6
Fairfield 6
Manchester 6
Phoenix 6
Tashkent 6
Dhaka 5
Guangzhou 5
Jyväskylä 5
Mumbai 5
Nuremberg 5
Zhengzhou 5
Biên Hòa 4
Düsseldorf 4
Guayaquil 4
La Paz 4
Medellín 4
Mexico City 4
Naples 4
Paris 4
Berlin 3
Brasília 3
Bến Tre 3
Elk Grove Village 3
Hải Dương 3
Juneau 3
Kuala Lumpur 3
Las Vegas 3
Nairobi 3
Totale 3.136
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 263
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 157
B cells in rheumatoid arthritis. 146
Antinuclear antibodies in systemic sclerosis 140
Disease-related malnutrition in systemic sclerosis: Evidences and implications 137
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 132
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 131
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 128
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 128
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 126
B cells in rheumatoid arthritis. 120
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 119
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 116
Fetal programming and systemic sclerosis 109
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 107
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 107
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 107
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 103
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 100
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 97
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 95
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 94
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 94
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 94
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 90
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 89
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 89
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 89
A 28-Year-Old Man with Stridor and Dyspnea 89
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 88
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 88
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 87
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 87
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 87
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 85
Pathophysiology of systemic sclerosis 83
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 81
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 80
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 80
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 77
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 74
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 73
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 68
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 67
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 60
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 42
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 32
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts 7
Totale 4.742
Categoria #
all - tutte 19.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022178 6 1 2 4 0 8 1 6 14 4 26 106
2022/2023688 71 66 12 62 58 68 1 42 273 5 22 8
2023/2024297 34 58 9 15 13 67 13 27 0 22 8 31
2024/2025975 21 45 9 22 15 90 93 81 242 41 102 214
2025/20262.022 147 103 221 227 225 114 329 106 201 140 93 116
Totale 4.742